SCHEMBL272011

SCHEMBL272011

BC1CC(OC(=O)OC)C(COP(=O)(O)OP(O)(=S)OP(=O)(O)O)O1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RY2 P41231 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL272516 0.90 P2RY2 (0.36) P2RY2
SCHEMBL271898 0.84 P2RY2 (0.32) P2RY2
SCHEMBL272010 0.83 P2RY2 (0.31) P2RY2
SCHEMBL272694 0.80 P2RY2 (0.37) P2RY2
SCHEMBL271990 0.78 P2RY2 (0.37) P2RY2
SCHEMBL272498 0.78 P2RY2 (0.36) P2RY2
SCHEMBL271873 0.77 P2RY2 (0.35) P2RY2
SCHEMBL271846 0.76
SCHEMBL18462970 0.76 P2RY2 (0.35) P2RY2
SCHEMBL25856556 0.74 POLB (0.36) P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133669-B2 Chemically modified nucleoside 5′-triphosphates for thermally initiated amplification of nucleic acid TRILINK BIOTECHNOLOGIES (US) 2012-03-13 US disclosed
US-20100003724-A1 CHEMICALLY MODIFIED NUCLEOSIDE 5'-TRIPHOSPHATES FOR THERMALLY INITIATED AMPLIFICATION OF NUCLEIC ACID TriLink Bio Technologies 2010-01-07 US disclosed